These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 8093295)

  • 61. [Quantitative determination of human bone marrow T cells following in vitro depletion by Campath-1 monoclonal antibody].
    Irlé C; Kaestli M; Chapuis B; Jeannet M
    Schweiz Med Wochenschr; 1985 Oct; 115(43):1517-8. PubMed ID: 3909385
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Graft-versus-host disease in children receiving HLA-identical allogeneic bone marrow transplants with a low adjusted T lymphocyte dose.
    Potter MN; Pamphilon DH; Cornish JM; Oakhill A
    Bone Marrow Transplant; 1991 Nov; 8(5):357-61. PubMed ID: 1768970
    [TBL] [Abstract][Full Text] [Related]  

  • 63. [Application of monoclonal antibodies to bone marrow transplantation].
    Morishima Y
    Gan To Kagaku Ryoho; 1988 May; 15(5):1693-701. PubMed ID: 3285796
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Comparative outcomes of T-cell-depleted and non-T-cell-depleted allogeneic bone marrow transplantation for chronic myelogenous leukemia: impact of donor lymphocyte infusion.
    Sehn LH; Alyea EP; Weller E; Canning C; Lee S; Ritz J; Antin JH; Soiffer RJ
    J Clin Oncol; 1999 Feb; 17(2):561-8. PubMed ID: 10080600
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Bone marrow transplantation with T-cell depleted allografts for the treatment of severe beta thalassemia major.
    Or R; Naparstek E; Aker M; Cividalli G; Engelhard D; Brautbar C; Weshler Z; Weiss L; Mumcuoglu M; Rachmilewitz EA
    Prog Clin Biol Res; 1989; 309():217-22. PubMed ID: 2675089
    [No Abstract]   [Full Text] [Related]  

  • 66. Irradiated donor buffy coat following T cell-depleted bone marrow transplants.
    Gratwohl A; Tichelli A; Würsch A; Dieterle A; Lori A; Thomssen C; Baldomero H; de Witte T; Nissen C; Speck B
    Bone Marrow Transplant; 1988 Nov; 3(6):577-82. PubMed ID: 3063326
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Transplantation of HLA-mismatched marrow depleted of T-cells by lectin agglutination and E-rosette depletion.
    O'Reilly RJ; Collins N; Dinsmore R; Kernan N; Siena S; Brochstein J; Kirkpatrick D; Flomenberg N; Shank B; Dupont B
    Tokai J Exp Clin Med; 1985 Jun; 10(2-3):99-107. PubMed ID: 3914748
    [No Abstract]   [Full Text] [Related]  

  • 68. Outcomes of transplantation with partial T-cell depletion of matched or mismatched unrelated or partially matched related donor bone marrow in children and adolescents with leukemias.
    Bunin N; Aplenc R; Leahey A; Magira E; Grupp S; Pierson G; Monos D
    Bone Marrow Transplant; 2005 Jan; 35(2):151-8. PubMed ID: 15531896
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Excessive T cell depletion of peripheral blood stem cells has an adverse effect upon outcome following allogeneic stem cell transplantation.
    Chakraverty R; Robinson S; Peggs K; Kottaridis PD; Watts MJ; Ings SJ; Hale G; Waldmann H; Linch DC; Goldstone AH; Mackinnon S
    Bone Marrow Transplant; 2001 Nov; 28(9):827-34. PubMed ID: 11781642
    [TBL] [Abstract][Full Text] [Related]  

  • 70. [Allogeneic bone marrow transplantation].
    Shibata H
    Gan To Kagaku Ryoho; 1988 Nov; 15(11):3044-52. PubMed ID: 3056276
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Bone marrow transplantation from genetically HLA-nonidentical donors in children with fatal inherited disorders excluding severe combined immunodeficiencies: use of two monoclonal antibodies to prevent graft rejection.
    Jabado N; Le Deist F; Cant A; De Graeff-Meeders ER; Fasth A; Morgan G; Vellodi A; Hale G; Bujan W; Thomas C; Cavazzana-Calvo M; Wijdenes J; Fischer A
    Pediatrics; 1996 Sep; 98(3 Pt 1):420-8. PubMed ID: 8784367
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Use of flow microfluorometry in bone marrow transplantation.
    Martin PJ; Hansen JA; Thomas ED
    Ann N Y Acad Sci; 1984; 428():14-25. PubMed ID: 6378022
    [No Abstract]   [Full Text] [Related]  

  • 73. Thymoglobulin prevents chronic graft-versus-host disease, chronic lung dysfunction, and late transplant-related mortality: long-term follow-up of a randomized trial in patients undergoing unrelated donor transplantation.
    Bacigalupo A; Lamparelli T; Barisione G; Bruzzi P; Guidi S; Alessandrino PE; di Bartolomeo P; Oneto R; Bruno B; Sacchi N; van Lint MT; Bosi A;
    Biol Blood Marrow Transplant; 2006 May; 12(5):560-5. PubMed ID: 16635791
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Allogeneic bone marrow transplantation for leukemia with marrow grafts treated by counterflow centrifugation.
    De Witte T; Schattenberg A; Preijers F; Raymakers R; Muus P; Wessels J
    Bone Marrow Transplant; 1993; 12 Suppl 3():S2-6. PubMed ID: 8124252
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Control of graft-versus-host disease and graft rejection by T cell depletion of donor and recipient with Campath-1 antibodies. Results of matched sibling transplants for malignant diseases.
    Hale G; Waldmann H
    Bone Marrow Transplant; 1994 May; 13(5):597-611. PubMed ID: 8054913
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Bone marrow transplantation for haemopoietic neoplasia. Evaluation of a new approach to T cell depletion.
    Speck B; Dazzi H; Gratwohl A; Tichelli A; Nissen C
    Bone Marrow Transplant; 1989 Dec; 4 Suppl 4():56-7. PubMed ID: 2627624
    [No Abstract]   [Full Text] [Related]  

  • 77. Prevention of graft-versus-host disease by selective depletion of CD6-positive T lymphocytes from donor bone marrow.
    Soiffer RJ; Murray C; Mauch P; Anderson KC; Freedman AS; Rabinowe SN; Takvorian T; Robertson MJ; Spector N; Gonin R
    J Clin Oncol; 1992 Jul; 10(7):1191-200. PubMed ID: 1607923
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Naïve T-Cell Depletion to Prevent GVHD: Searching for a Better Mousetrap.
    Soiffer RJ
    J Clin Oncol; 2022 Apr; 40(11):1139-1141. PubMed ID: 35213234
    [No Abstract]   [Full Text] [Related]  

  • 79. Donor leukocyte infusion as therapy of life-threatening adenoviral infections after T-cell-depleted bone marrow transplantation.
    Hromas R; Cornetta K; Srour E; Blanke C; Broun ER
    Blood; 1994 Sep; 84(5):1689-90. PubMed ID: 8068960
    [No Abstract]   [Full Text] [Related]  

  • 80. Kaplan-Meier, marginal or conditional probability curves in summarizing competing risks failure time data?
    Pepe MS; Mori M
    Stat Med; 1993 Apr; 12(8):737-51. PubMed ID: 8516591
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.